People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA, the chemical found in ecstasy. In August, the Food and Drug Administration plans to decide whether MDMA-assisted therapy for PTSD will be approved for market based on years of research.
Federal health advisers are considering the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. Advisers to the Food and Drug Administration are scheduled to
A federal advisory committee meets today to weigh the risks and benefits of using MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder.
The U.S. Food and Drug Administration held a meeting to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder for the first time.
The FDA will review data to decide whether to approve MDMA, also known as ecstasy, for PTSD treatment. Biden is expected to issue an executive order addressing asylum seekers at the southern border.
There's excitement and controversy swirling around the potential use of MDMA for treating post-traumatic stress disorder. On Tuesday, a panel of advisers to the FDA will evaluate the data.
WASHINGTON — Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD, handing a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medic…
WASHINGTON — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hop
The panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of MDMA when used to treat post-traumatic stress disorder
A panel of advisers to the FDA voted against the overall benefits of MDMA when used to treat PTSD, citing flawed study data, questionable research conduct and significant drug risks, including the potential for heart problems, injury and abuse.
A panel of US health experts convened by the Food and Drug Administration on Tuesday overwhelmingly voted against the use of MDMA, commonly known as ecstasy, to treat post-traumatic stress
Showing the first 25 of 38 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Supporters think ecstasy has potential to treat PTSD, but FDA panel rejects psychedelic drug | Since Then
